Seeking Alpha

cnylax44

cnylax44
Send Message
View as an RSS Feed
View cnylax44's Comments BY TICKER:
Latest  |  Highest rated
  • Alexion Pharmaceuticals Will Rise Again [View article]
    Strange that you make absolutely no comment on the maturing internal pipeline at ALXN. It may be good to read some of the research reports that go into significant detail.
    Aug 24, 2015. 08:59 AM | Likes Like |Link to Comment
  • American Airlines Investors Are Ignoring Major Risks To The Company [View article]
    This piece is beyond poor. Maybe you're new to the investing game bur AAL is NOT "currently a very popular long" --- having declined over 20% YEAR TO DATE in one of the poorest performing sectors in the market. AAL was a great performer BEFORE the airline space got crowded & provided superior returns. Did you know that ?

    Please keep us posted on "the stock market crash being predicted by almost everyone" ----that is a hoot ! Everyone KNOWS that there is a crash coming ! That's great to know. And finally if AAL is so bad why not short it ??? Please do some homework before posting such gibberish.
    Jun 23, 2015. 06:05 AM | 6 Likes Like |Link to Comment
  • Game Plan For The Week - Cramer's Mad Money (5/29/15) [View article]
    Sell airlines ??? Buy Buy Buy AAL in the $50s, now sell in the $40s. Cramer does the Chuck Connors Rifleman routine----shoots all over the map. Pity the poor retail investor taking such "guidance".
    Jun 1, 2015. 09:08 AM | 3 Likes Like |Link to Comment
  • Is Tableau Still A Better Investment Than Splunk? [View article]
    "Value investing" ???? Tableau ? Splunk? looks like you're on the aggressive growth path here----no GARP here.
    May 31, 2015. 03:18 PM | 1 Like Like |Link to Comment
  • Michael Kors: Investors Overreact On Q4 2015 Earnings Release [View article]
    The fundamentals are very strong ? Is that why the stock has been cut in half ? Which of the last FOUR earnings releases are investors overreacting to ?
    May 28, 2015. 04:19 PM | Likes Like |Link to Comment
  • MEI Pharma To Move Pracinostat Into Phase 3 As Data In Elderly AML Continues To Impress [View article]
    Cantor Fitzgerald recommends MEIP with a $7 target price.
    May 27, 2015. 09:32 AM | 1 Like Like |Link to Comment
  • Gilead Sciences - No Need To Gild The Lily [View article]
    Are you saying you have no idea as to why GILD has been trending sideways for almost the last year ? Maybe it would be a good idea for you to read some of the voluminous research reports that are available on the company.
    May 12, 2015. 11:34 AM | 5 Likes Like |Link to Comment
  • Baker Brothers' Holding Cerus Flying Under The Radar With Catalyst Upcoming [View article]
    XOMA has been a loser for 25 years---amazing that they're still around. I wondered why the Bakers got involved with this pooch & weren't surprised when then cut their position. Its funny how people follow other people blind.
    May 5, 2015. 11:06 PM | Likes Like |Link to Comment
  • Baker Brothers' Holding Cerus Flying Under The Radar With Catalyst Upcoming [View article]
    CERS has been a great stock to avoid over the last 5 years. It show not to follow others blindly into stocks.
    May 5, 2015. 11:03 PM | Likes Like |Link to Comment
  • American Airlines: Market Still Underestimating The Benefits Of Lower Fuel Prices [View article]
    You must be new to the airline sector as this data has been published many many times. Did you know that airline stocks were the big winners LAST year ?
    Apr 23, 2015. 03:20 PM | Likes Like |Link to Comment
  • ACADIA Pharmaceuticals At $30: The Upside Doesn't Justify The Risk [View article]
    Kaz---I think you need to speak to key people INSIDE the company to know what's going on. Reposting a prèss release is nice but generally filled with some fluff---as this one is.
    Apr 7, 2015. 11:49 PM | Likes Like |Link to Comment
  • Alexion Pharma Is A 'Wait And See' Story [View article]
    No doubt you are showing up at the curb at the same time and trying to make an investment judgment as if this was an auto company. Good luck to you as well. Premier biotech companies like ALXN earn their stripes every day so if you want to show and guesstimate what's going on at the company you are more than welcome to do just that. That's why most retail people are hardly aware of this $35+ Billion market cap company. I guess T Rowe, Fidelity, Capital Guardian with their $billions$ invested in ALXN do not closely share yours or the rookie author's opinion on the company's outlook. No surprise there at all. Numbers don't lie----CONSISTENT 30+% top line & bottom line performance---quarter after quarter---year after year----get in the game. Do some homework---it may help you out possibly some day. People do lie and lazy people get hurt-------try to avoid that trap.
    Apr 7, 2015. 11:45 PM | 1 Like Like |Link to Comment
  • Alexion Pharma Is A 'Wait And See' Story [View article]
    It's clear that you are new to the ALXN story & obviously not close to what is going on at the company. Perhaps you go back and read the quarterly conference calls over the last 3 to 4 years to give you a closer feel. There are also some excellent sell-side research reports that may give you insight as to why ALXN has been one of the most powerful and innovative growth stories over the last decade and remains so going forward. Please do some real work next time as this "analysis" hardly tells investors what is gong on.
    Apr 7, 2015. 08:21 PM | 1 Like Like |Link to Comment
  • What Rite Aid Investors Should Expect From Earnings, Guidance And The Stock [View article]
    Not much new here. Stay the course---the trend remains strong, especially with March same store sales comparisons up 4.3% in March. Company guidance will be conservative so that they can meet & beat. No surprise there.
    Apr 4, 2015. 01:10 PM | 1 Like Like |Link to Comment
  • ACADIA Pharmaceuticals At $30: The Upside Doesn't Justify The Risk [View article]
    Good analysis---as this operational disaster under the previous CEO isn't being fixed overnight. Wall Street analysts are drinking the "potential" Kool-Aid and not digging enough to see the difficulties inside the company. I wouldn't be surprised at all to see further delays as ACAD continues to struggle internally.
    Mar 26, 2015. 01:33 PM | 3 Likes Like |Link to Comment
COMMENTS STATS
135 Comments
82 Likes